Press releases
- Genomma Lab Internacional S.A.B. de C.V. Second Quarter 2024 Earnings Results Conference Call
- GENOMMA LAB INTERNACIONAL ANNOUNCES EIGHTH DIVIDEND PAYMENT
- Marzam's New Strategy Will Focus on Strengthening the Company's Position within Pharmaceutical Sector
- Agreement Signed for Share Redemption in Marzam
- Genomma Lab Internacional Announces Results for the First Quarter 2024
- Genomma Lab Internacional S.A.B. de C.V. First Quarter 2024 Earnings Results Conference Call
More ▼
Key statistics
As of last trade, Genomma Lab Internacional SAB de CV (GEKA:FRA) traded at 0.815, 24.43% above the 52 week low of 0.655 set on Oct 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.815 |
---|---|
High | 0.815 |
Low | 0.815 |
Bid | 0.815 |
Offer | 0.86 |
Previous close | 0.835 |
Average volume | 0.00 |
---|---|
Shares outstanding | 1.02bn |
Free float | 784.98m |
P/E (TTM) | 14.34 |
Market cap | 16.75bn MXN |
EPS (TTM) | 1.14 MXN |
Annual div (ADY) | 0.0201 EUR |
---|---|
Annual div yield (ADY) | 2.41% |
Div ex-date | Jun 20 2024 |
Div pay-date | Jun 21 2024 |
Data delayed at least 15 minutes, as of Jul 03 2024 08:01 BST.
More ▼